0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

NEWER ASPECTS OF THE THERAPEUTICS OF VIOSTEROL (IRRADIATED ERGOSTEROL)

A. F. HESS, M.D.; J. M. LEWIS, M.D.; HELEN RIVKIN, M.A.
JAMA. 1930;94(24):1885-1889. doi:10.1001/jama.1930.02710500003002.
Text Size: A A A
Published online

In June, 1924, it was announced by Hess, and in September of the same year by Steenbock, that inert substances can be endowed with antirachitic potency by means of ultraviolet irradiation.1 Less than two years later, Windaus and Hess2 and Rosenheim and Webster3 shed further light on this subject by showing that it is ergosterol which undergoes this remarkable metamorphosis. During the short period which has followed, much has been learned and the advance has been steady and significant, but this aspect of pharmacology is so novel that it is not surprising that much remains to be explored and elucidated.

As is true of nutritional disorders in general, so of rickets the most important realm of therapeutics is that of prevention. With this goal in view we attempted the absolute prevention of rickets in sixty infants, from 4 to 12 months of age, by giving, in the

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();